Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma

In this study, we evaluated an NF-κB inducing kinase (NIK) inhibitor, CW15337, in primary chronic lymphocytic leukemia (CLL) cells, CLL and multiple myeloma (MM) cell lines and normal B- and T-lymphocytes. Basal NF-κB subunit activity was characterized using an enzyme linked immunosorbent assay (ELI...

Full description

Bibliographic Details
Main Authors: Thomas A. Burley, Emma Kennedy, Georgia Broad, Melanie Boyd, David Li, Timothy Woo, Christopher West, Eleni E. Ladikou, Iona Ashworth, Christopher Fegan, Rosalynd Johnston, Simon Mitchell, Simon P. Mackay, Andrea G. S. Pepper, Chris Pepper
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
NF-κB inducing kinase
chronic lymphocytic leukemia
multiple myeloma
NF-κB
synergy
Online Access:https://www.mdpi.com/2072-6694/14/6/1489

Internet

https://www.mdpi.com/2072-6694/14/6/1489

Similar Items